Financial News
Medmira (TSV: MIR )
Press Releases about Medmira
MedMira Reports First Quarter Results FY2025
December 30, 2024
MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
November 28, 2024
MedMira Reports Third Quarter Results FY2024
July 02, 2024
MedMira Reports Second Quarter Results FY2024
April 01, 2024
Corporate Update on Clinical Evaluation of MedMira’s Products
February 01, 2024
MedMira Reports First Quarter Results FY2024
December 29, 2023
MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
November 28, 2023
Progress Update on Securities
August 30, 2023
MedMira Reports Third Quarter Results FY2023
June 29, 2023
Update on MedMira’s Regulatory Path in Canada and the USA
September 27, 2023
MedMira Reports Second Quarter Results FY2023
April 03, 2023
MedMira Enters into Partnership with Maternova for USA and Latin America
February 20, 2023
MedMira Reports First Quarter Results FY2023
December 30, 2022
MedMira Reports FY2021 Fourth Quarter and Year End Financial Results
November 29, 2022
MedMira receives CE mark for its VYRA(TM) CoV2Flu Antigen Test
January 11, 2023
MedMira Introduces VYRA TriDemic
December 29, 2022
MedMira Receives CE Mark for Its VYRA(TM) COVID-19 Antigen Test
October 14, 2022
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
